awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48538147-1FDE7164-E34B-48E7-99F4-DD0BD5F25A02
Q48538147-1FDE7164-E34B-48E7-99F4-DD0BD5F25A02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48538147-1FDE7164-E34B-48E7-99F4-DD0BD5F25A02
A phase II trial with bevacizumab and irinotecan for patients with primary brain tumors and progression after standard therapy.
P2860
Q48538147-1FDE7164-E34B-48E7-99F4-DD0BD5F25A02
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48538147-1FDE7164-E34B-48E7-99F4-DD0BD5F25A02
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1862ea1fca74288b621735c7663bef9798f18950
P2860
Bevacizumab for recurrent ependymoma.